⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Pentadecanoic Acid (C15:0)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-10 — Effect of Pentadecanoic Acid Supplementation on Red Blood Cell Health and Biological Aging in Healthy Older Adults: Phase II RCT protocol registered (n TBD, adults ≥55, 200–300 mg/day C15:0 for 12 weeks vs placebo) with primary endpoint RDW-CV and secondary biological-age biomarkers — protocol only, no results yet. [human-rct] (novelty: 3)
Open questions
Related
Contributing findings
Effect of Pentadecanoic Acid Supplementation on Red Blood Cell Health and Biological Aging in Healthy Older Adults
10-sep-2026
novelty 3
per-area 3
strengthens